樂觀
$44.59
情境價格
$8.090
-0.214 (-2.65%)收盤時
FMC Corporation is a global agricultural sciences company engaged in providing farmers solutions that increase the productivity and resilience of their land. The Company’s crop protection solutions, including biologicals, crop nutrition, digital and precision agriculture, enable growers and crop advisers to address their challenges economically while protecting the environment. Its portfolio consists of three major pesticide categories: insecticides, herbicides and fungicides. The majority of its product lines consist of insecticides and herbicides, and it has a portfolio of fungicides mainly used in high-value crop segments. Its insecticides are used to control a wide spectrum of pests, while its herbicide portfolio primarily targets a large variety of difficult-to-control weeds. In addition, it is also investing in its Plant Health program, which includes biologicals, crop nutrition, and seed treatment products. Biological technologies serve as complements to its synthetic products.
FMC Corp is not a good buy right now due to its current price of $8.35 being significantly below the lowest analyst target of $10 and a troubling RSI of 24.247 indicating oversold conditions. The company's financial performance shows a staggering 71.73% decline over the past year, and its debt-to-equity ratio is alarmingly high at 257.70%, indicating potential financial instability. The main risk is the ongoing net losses, with a net income of -186600000 in Q2 2026, which raises concerns about the company's ability to recover and generate profits in the near future.
BMO Capital
$11
2026-10-06
BMO Capital
2026-10-06
目標價
$11
UBS
$10
2026-10-05
UBS
2026-10-05
目標價
$10
Seaport Research
$21
2026-08-04
Seaport Research
2026-08-04
目標價
$21
RBC Capital
$11
2026-08-03
RBC Capital
2026-08-03
目標價
$11
Morgan Stanley
$12
2026-07-31
Morgan Stanley
2026-07-31
目標價
$12
情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

FMC Submits New Herbicide Application

FMC Submits Rimisoaxfen Regulatory Filing in Brazil

FMC Advances Rimisoxafen Regulatory Filing in Brazil

FMC and Tessenderlo Finalize Minority Equity Investment Agreement

FMC and Tessenderlo Finalize Minority Equity Investment Agreement
FMC Corporation is a global agricultural sciences company engaged in providing farmers solutions that increase the productivity and resilience of their land. The Company’s crop protection solutions, including biologicals, crop nutrition, digital and precision agriculture, enable growers and crop advisers to address their challenges economically while protecting the environment. Its portfolio consists of three major pesticide categories: insecticides, herbicides and fungicides. The majority of its product lines consist of insecticides and herbicides, and it has a portfolio of fungicides mainly used in high-value crop segments. Its insecticides are used to control a wide spectrum of pests, while its herbicide portfolio primarily targets a large variety of difficult-to-control weeds. In addition, it is also investing in its Plant Health program, which includes biologicals, crop nutrition, and seed treatment products. Biological technologies serve as complements to its synthetic products. It operates in the Basic Materials sector (CHEMICALS & ALLIED PRODUCTS industry).
FMC Corp is not a good buy right now due to its current price of $8.35 being significantly below the lowest analyst target of $10 and a troubling RSI of 24.247 indicating oversold conditions. The company's financial performance shows a staggering 71.73% decline over the past year, and its debt-to-equity ratio is alarmingly high at 257.70%, indicating potential financial instability. The main risk is the ongoing net losses, with a net income of -186600000 in Q2 2026, which raises concerns about the company's ability to recover and generate profits in the near future.
21 analysts cover FMC: 13 rate it Buy, 8 Hold and 0 Sell. The average price target is 19.08.
暫無貼文
註冊或登入後參與討論本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。